Peptide Drug Summit Opens in Munich With Focus on Delivery and Oral Bioavailability
The two-day Peptide Drug Summit begins today in Munich, gathering developers to tackle the stability and delivery hurdles that still limit many peptide therapeutics.
Source: BioM — Peptide Drug Summit 2026
FDA Advisory Panel Backs Six Peptides for Compounding — But Final Rulemaking Still Pending
The Pharmacy Compounding Advisory Committee's July 2026 recommendation for BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax moves the needle, but pharmacies still cannot legally compound these peptides until FDA formally amends the 503A Bulks List.
Source: AJMC
Global Peptide Synthesis Market Hits $1.9 Billion as Demand Surges
A new industry report shows the global research peptide market has reached $1.9 billion in 2026, driven by therapeutic demand and projected to hit $2.59 billion by 2031.
Source: GlobeNewsWire
FDA Approves Foundayo (Orforglipron) — First Daily Oral GLP-1 Pill for Weight Loss
Eli Lilly's Foundayo becomes the first once-daily oral GLP-1 receptor agonist approved by the FDA, eliminating the need for injections in obesity treatment.
Source: Medical News Today
Daily Briefing
Get the latest peptide research delivered to your inbox every morning.
The Peptide Wizard
High-quality research peptides for lab use. Third-party tested with certificate of analysis available on every product.
Visit The Peptide WizardSponsored content. ThePBrief receives compensation. For research purposes only.